Participants also reported reduced food cravings, but this varied by GLP-1 group
Nausea, vomiting, diarrhea, constipation, abdominal pain , and bloating show up regularly in trials and real-world use
Medical guidelines state the drug is unlikely to work long-term if you haven't lost 3% to 5% of your starting weight after 12 weeks on a full dose
30
RGA health insurance experts are actively engaging with insurers to help determine optimal paths forward with the GLP-1 impact and other emerging issues
TB-500, a synthetic fraction of thymosin beta-4, is studied for its role in promoting cell migration, endothelial cell differentiation, and down-regulating inflammatory cytokines